Indeed, VISTA can be substantially overexpressed in the tumor-infiltrating immune cells of various cancers, e.g., melanoma (43, 44), gastric cancer (19), prostate cancer (45), colorectal cancer (46), and acute myeloid leukemia (47). Here, VSIR is linked to cancer.